AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.

Wong, Meihong; Funasaka, Kohei; Obayashi, Tomohiko; Miyahara, Ryoji; Hirooka, Yoshiki; Hamaguchi, Michinari; Goto, Hidemi; Senga, Takeshi

Wong, Meihong; Funasaka, Kohei; Obayashi, Tomohiko; Miyahara, Ryoji; Hirooka, Yoshiki; Hamaguchi, Michinari; Goto, Hidemi; Senga, Takeshi.

Afiliación

Wong M; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Funasaka K; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Obayashi T; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Miyahara R; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Hirooka Y; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Hamaguchi M; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Goto H; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Senga T; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Oncol Lett ; 13(3): 1281-1287, 2017 Mar.

Article en En | MEDLINE | ID: mdl-28454247

Palabras clave

KIT; adenosine monophosphate deaminase 3; gastrointestinal stromal tumors; imatinib; invasion; migration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google